Mangoceuticals (MGRX) Interest Expenses (2025)

Mangoceuticals' (MGRX) quarterly Interest Expenses came in at $19663.0 in Q4 2025, down 74.08% quarter-over-quarter from $75850.0 in Q3 2025.

Mangoceuticals (MGRX) Interest Expenses (2025) Analysis & Trends

Mangoceuticals has disclosed Interest Expenses across 1 years of filings, most recently posting $19663.0 for Q4 2025.

Interest Expenses for Q4 2025 came in at $19663.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $117213.0 (up 955.57% YoY), and the FY2025 annual result was $103513.0, up 655.57% from the prior year.
Interest Expenses came in at $19663.0 for Q4 2025 at Mangoceuticals, down from $75850.0 in the prior quarter.
In the past five years, Interest Expenses ranged from a high of $75850.0 in Q3 2025 to a low of -$13700.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	-
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	38.62 Mn
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	12.59 Mn
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	-
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	20.65 Mn
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	-
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	-
10	Mangoceuticals	5.25 Mn	5.06 Mn	29,001.00	-

Download Data